Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Michelle Brauer, BS
Advertisement
Articles by Michelle Brauer, BS
Advertisement
Latest Updated Articles
- The Potential Impact of CAR T-Cell Treatment Delays on Society
Published: August 13th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
2
Physical Activity, Vaccination May Protect Against Long COVID
3
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
4
mRNA COVID-19 Vaccines Not Associated With Major Congenital Malformations During Pregnancy
5
